What is DocPlix?
DocPlix operates within the burgeoning medtech sector, offering a comprehensive healthcare management platform designed to streamline operations and enhance patient care. The company's focus on integrating technology into healthcare solutions positions it as a key player in India's digital health landscape. This enterprise-level funding suggests a strategic move towards scaling its operations and expanding its market reach.
How much funding has DocPlix raised?
DocPlix has raised a total of $747K across 2 funding rounds:
Other Financing Round
$604K
Debt
$143K
Other Financing Round (2023): $604K with participation from Eris Lifesciences
Debt (2024): $143K led by Inflection Point Ventures
Key Investors in DocPlix
Eris Lifesciences
Eris Lifesciences Ltd is a prominent Indian pharmaceutical company specializing in branded formulations, particularly in the cardio-metabolic sector. The company offers a diverse range of products across various therapeutic areas including anti-diabetes, cardiovascular health, dermatology, and gynecology.
Inflection Point Ventures
IPV Inflection Point Ventures is India's leading angel investing platform focused on providing viable investment opportunities for investors while being founder-friendly. The company aims to create the world's most accessible angel-investing network by offering both funding and non-monetary support to startups for their growth and scalability.
What's next for DocPlix?
With the recent major strategic investment, DocPlix is poised for accelerated growth and enhanced service delivery. The company is likely to leverage this capital to further develop its platform, expand its technological capabilities, and potentially broaden its geographical footprint. This backing signifies strong investor confidence in DocPlix's business model and its potential to disrupt the healthcare management industry.
See full DocPlix company page
